In the US, Lenalidomide (lenalidomide systemic) is a member of the following drug classes: miscellaneous antineoplastics, other immunosuppressants and is used to treat Anemia, Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma and Myelodysplastic Diseases.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
- Lenalidomidum (Latin)
- Lenalidomid (German)
- Lenalidomide (French)
- Lenalidomida (Spanish)
- Lenalidomide (OS: BAN, USAN)
- CC-5013 (IS: Cellgene-Corporation)
- CC-5053 (IS)
- CDC-5013 (IS)
- ENMD-0997 (IS)
- IMiD3 (IS)
Laboratorio LKM, Vietnam; LKM, Argentina
Asofarma de Mexico, Mexico; Celgene, Austria; Celgene, Australia; Celgene, Belgium; Celgene, Canada; Celgene, Switzerland; Celgene, Czech Republic; Celgene, Germany; Celgene, Denmark; Celgene, Egypt; Celgene, Spain; Celgene, Finland; Celgene, France; Celgene, United Kingdom; Celgene, Hong Kong; Celgene, Hungary; Celgene, Ireland; Celgene, Israel; Celgene, Iceland; Celgene, Italy; Celgene, Japan; Celgene, Lithuania; Celgene, Latvia; Celgene, Netherlands; Celgene, Norway; Celgene, New Zealand; Celgene, Poland; Celgene, Portugal; Celgene, Sweden; Celgene, Turkey; Celgene, United States; Celgene Europe, Bosnia & Herzegowina; Celgene Europe, Greece; Medical Intertrade, Croatia (Hrvatska); Medicamenta Ecuatoriana, Ecuador; Tecnofarma, Chile
|BAN||British Approved Name|
|IUPAC||International Union of Pure and Applied Chemistry|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.